Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

HICL Infrastructure disposes of seven UK PPP assets

(Sharecast News) - Infrastructure investor HICL Infrastructure said on Monday that it had agreed to dispose of a portfolio of seven UK public private partnership assets to Dutch pension services provider APG, for a total consideration of roughly £225m. HICL said the portfolio made up 50% of its investments in Southmead Hospital, and Pinderfields and Pontefract Hospitals, as well as its entire equity interest in four UK LIFT projects and Edinburgh Schools.

It also noted that the consideration included cash distributions received since 1 April and was in line with the last audited valuation of the assets. The majority of the consideration will be received on completion, with a small non-contingent deferred element of £14m due by 30 June 2026.

HICL said proceeds will be used to repay the £30m drawn from its revolving credit facility, fund £110m of investment commitments, and support its £150m share buyback programme, which has already delivered 1.8p of net asset value accretion.

Separately, HICL said it operational performance remained solid across the portfolio, with yield assets underpinning cash generation and growth assets progressing capex plans. Affinity Water and Texas Nevada Transmission both traded in line with expectations.

HICL also reiterated its covered dividend target of 8.35p for FY26 and 8.50p for FY27. With £725m of disposals announced over the past two years, HICL said it remains well positioned to pursue selective acquisitions and further buybacks, supported by a resilient balance sheet and stable cashflows.

As of 0840 BST, HICL shares were up 1.06% at 120.26p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.